GeoVax Labs Files Q1 2025 10-Q
Ticker: GOVX · Form: 10-Q · Filed: May 1, 2025 · CIK: 832489
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials, contracts
TL;DR
GeoVax Labs Q1 2025 10-Q filed. BARDA contracts & consulting expenses detailed.
AI Summary
GeoVax Labs, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates, including information related to BARDA contracts and expenses from consulting and investment banking agreements. The company's fiscal year ends on December 31st.
Why It Matters
This filing provides investors with a quarterly update on GeoVax Labs' financial health and strategic activities, crucial for understanding the company's progress in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, GeoVax Labs faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-01 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- GeoVax Labs, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250501 (date) — Filing date
- BARDA (company) — Mentioned in relation to contracts
FAQ
What were the key financial highlights for GeoVax Labs in Q1 2025?
The filing does not provide specific dollar amounts for Q1 2025 financial highlights, but it does mention expenses related to consulting and investment banking agreements for both Q1 2025 and Q1 2024, and details BARDA contracts.
Are there any significant subsequent events mentioned in the filing?
Yes, the filing mentions 'SubsequentEventMember' and a period from April 1, 2025, to April 30, 2025, indicating events that occurred after the reporting period.
What is the company's primary industry classification?
GeoVax Labs, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
What is the fiscal year end for GeoVax Labs?
The fiscal year end for GeoVax Labs is December 31st.
Does the filing mention any specific contracts or grants?
Yes, the filing specifically mentions 'BARDAContractMember' and 'us-gaap:GrantMember' in relation to the period of January 1, 2025, to March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding GeoVax Labs, Inc. (GOVX).